C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Purchases New Holdings in Teladoc Health, Inc. (NYSE:TDOC)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in Teladoc Health, Inc. (NYSE:TDOC) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 29,882 shares of the health services provider’s stock, valued at approximately $272,000.

Several other hedge funds have also recently modified their holdings of the business. Rhumbline Advisers lifted its position in shares of Teladoc Health by 1.8% in the 4th quarter. Rhumbline Advisers now owns 281,420 shares of the health services provider’s stock worth $2,558,000 after purchasing an additional 5,018 shares during the period. Allspring Global Investments Holdings LLC purchased a new stake in shares of Teladoc Health in the 4th quarter worth approximately $2,859,000. Summit Trail Advisors LLC purchased a new stake in shares of Teladoc Health in the 4th quarter worth approximately $92,000. Murphy Pohlad Asset Management LLC purchased a new stake in shares of Teladoc Health in the 4th quarter worth approximately $458,000. Finally, Robeco Institutional Asset Management B.V. lifted its position in shares of Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock worth $6,365,000 after purchasing an additional 125,111 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. TD Cowen lowered their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Finally, Barclays boosted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health presently has an average rating of “Hold” and a consensus price target of $12.18.

Insider Transactions at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.95% of the company’s stock.

Teladoc Health Stock Down 7.4 %

NYSE:TDOC opened at $12.75 on Friday. The firm has a market capitalization of $2.19 billion, a P/E ratio of -2.21 and a beta of 1.05. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $16.82. The company’s fifty day moving average price is $10.52 and its 200-day moving average price is $9.41. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.